Login to Your Account



Alkermes Bags Elan Drug Delivery Unit for $960M

By Nuala Moran


Wednesday, May 11, 2011
LONDON – Alkermes Inc. is acquiring the drug delivery arm of Elan plc in a cash and shares deal valued at $960 million. Of that Elan will receive $500 million cash, with the balance coming in the form of 31.9 million shares. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription